• Media Report

    • NEWS

    Home > News

    Title Date
    1 Press Release: Sparking Synergy! CHO Pharma and StemCyte Combine Antibody with Homogenous Glycan and Cell Therapy to Develop New Cancer Therapy.   2022-06-28
    2 Additional Information Regarding the Clarification Statement Released by Genomic Research Center, Academia Sinica on April 19, 2022   2022-04-20
    3 The number of approved patents has doubled, with a total of 119 patents   2021-09-22
    4 Press Release-CHO Pharma signed a MoU with Mycenax   2021-06-15
    5 CHO Pharma was selected for the “CDE can Help: COVID-19 special science counseling”   2021-05-24
    6 CHO Pharma signs MoU with MetaTech, the first collaboration between regenerative medicine and anti-glycan Antibody   2020-05-29
    7 CHO Pharma receives the 16th National Innovation Award - Pharmaceutical Category   2019-12-06
    8 Comprehensive Patent Portfolio   2020-03-31